BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30369320)

  • 1. Assessing Baseline and Temporal Changes in Cardiometabolic Risk Using Metabolic Syndrome Severity and Common Risk Scores.
    Gurka MJ; Filipp SL; Pearson TA; DeBoer MD
    J Am Heart Assoc; 2018 Aug; 7(16):e009754. PubMed ID: 30369320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a Metabolic Syndrome Severity
    DeBoer MD; Filipp SL; Gurka MJ
    Diabetes Care; 2018 Nov; 41(11):2421-2430. PubMed ID: 30275282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome severity is significantly associated with future coronary heart disease in Type 2 diabetes.
    Gurka MJ; Guo Y; Filipp SL; DeBoer MD
    Cardiovasc Diabetol; 2018 Jan; 17(1):17. PubMed ID: 29351794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discordance of Low-Density Lipoprotein and High-Density Lipoprotein Cholesterol Particle Versus Cholesterol Concentration for the Prediction of Cardiovascular Disease in Patients With Metabolic Syndrome and Diabetes Mellitus (from the Multi-Ethnic Study of Atherosclerosis [MESA]).
    Tehrani DM; Zhao Y; Blaha MJ; Mora S; Mackey RH; Michos ED; Budoff MJ; Cromwell W; Otvos JD; Rosenblit PD; Wong ND
    Am J Cardiol; 2016 Jun; 117(12):1921-7. PubMed ID: 27156827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
    Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
    J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of metabolic syndrome score by confirmatory factor analysis in children and adults and prediction of cardiometabolic outcomes in adults.
    Viitasalo A; Lakka TA; Laaksonen DE; Savonen K; Lakka HM; Hassinen M; Komulainen P; Tompuri T; Kurl S; Laukkanen JA; Rauramaa R
    Diabetologia; 2014 May; 57(5):940-9. PubMed ID: 24463933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.
    Meis SB; Schuster D; Gaillard T; Osei K
    Ethn Dis; 2006; 16(4):830-6. PubMed ID: 17061734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LIPID ACCUMULATION PRODUCT, VISCERAL ADIPOSITY INDEX, AND CHINESE VISCERAL ADIPOSITY INDEX AS MARKERS OF CARDIOMETABOLIC RISK IN ADULT GROWTH HORMONE DEFICIENCY PATIENTS: A CROSS-SECTIONAL STUDY.
    Xie X; Li Q; Zhang L; Ren W
    Endocr Pract; 2018 Jan; 24(1):33-39. PubMed ID: 29144802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure-weighted scoring for metabolic syndrome and the risk of myocardial infarction and stroke: a nationwide population-based study.
    Lee EY; Han K; Kim DH; Park YM; Kwon HS; Yoon KH; Kim MK; Lee SH
    Cardiovasc Diabetol; 2020 Sep; 19(1):153. PubMed ID: 32993664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inter-relationships between the severity of metabolic syndrome, insulin and adiponectin and their relationship to future type 2 diabetes and cardiovascular disease.
    DeBoer MD; Gurka MJ; Morrison JA; Woo JG
    Int J Obes (Lond); 2016 Sep; 40(9):1353-9. PubMed ID: 27133621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome and 10-year cardiovascular disease incidence: The ATTICA study.
    Kastorini CM; Panagiotakos DB; Georgousopoulou EN; Laskaris A; Skourlis N; Zana A; Chatzinikolaou C; Chrysohoou C; Puddu PE; Tousoulis D; Stefanadis C; Pitsavos C;
    Nutr Metab Cardiovasc Dis; 2016 Mar; 26(3):223-31. PubMed ID: 26803591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multisite atherosclerosis in subjects with metabolic syndrome and diabetes and relation to cardiovascular events: The Multi-Ethnic Study of Atherosclerosis.
    Zhao Y; Evans MA; Allison MA; Bertoni AG; Budoff MJ; Criqui MH; Malik S; Ouyang P; Polak JF; Wong ND
    Atherosclerosis; 2019 Mar; 282():202-209. PubMed ID: 30600075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The severity of the metabolic syndrome increases over time within individuals, independent of baseline metabolic syndrome status and medication use: The Atherosclerosis Risk in Communities Study.
    Vishnu A; Gurka MJ; DeBoer MD
    Atherosclerosis; 2015 Nov; 243(1):278-85. PubMed ID: 26409627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome, glucose tolerance categories and the cardiovascular risk in Spanish population.
    Martínez-Larrad MT; Corbatón-Anchuelo A; Fernández-Pérez C; Lazcano-Redondo Y; Escobar-Jiménez F; Serrano-Ríos M
    Diabetes Res Clin Pract; 2016 Apr; 114():23-31. PubMed ID: 27103365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of a metabolic syndrome severity score with coronary heart disease and diabetes in fasting vs. non-fasting individuals.
    DeBoer MD; Filipp SL; Gurka MJ
    Nutr Metab Cardiovasc Dis; 2020 Jan; 30(1):92-98. PubMed ID: 31662283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of BMI as the marker of adiposity in a metabolic syndrome severity score: Derivation and validation in predicting long-term disease outcomes.
    Gurka MJ; Filipp SL; Musani SK; Sims M; DeBoer MD
    Metabolism; 2018 Jun; 83():68-74. PubMed ID: 29410278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of two metabolic syndrome definitions in the estimation of cardiovascular disease among hypertensive patients.
    Hirota AH; Rodrigues CJ; Borges RL; Ribeiro AB; Zanella MT; Batista MC
    J Clin Hypertens (Greenwich); 2010 Aug; 12(8):588-96. PubMed ID: 20695935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a metabolic syndrome severity score and its association with incident diabetes in an Asian population-results from a longitudinal cohort in Singapore.
    Low S; Khoo KCJ; Wang J; Irwan B; Sum CF; Subramaniam T; Lim SC; Wong TKM
    Endocrine; 2019 Jul; 65(1):73-80. PubMed ID: 31161560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular Risk Factor Targets and Cardiovascular Disease Event Risk in Diabetes: A Pooling Project of the Atherosclerosis Risk in Communities Study, Multi-Ethnic Study of Atherosclerosis, and Jackson Heart Study.
    Wong ND; Zhao Y; Patel R; Patao C; Malik S; Bertoni AG; Correa A; Folsom AR; Kachroo S; Mukherjee J; Taylor H; Selvin E
    Diabetes Care; 2016 May; 39(5):668-76. PubMed ID: 27208374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary calcium density in relation to coronary heart disease and cardiovascular disease in adults with diabetes or metabolic syndrome: the Multi-ethnic Study of Atherosclerosis (MESA).
    Zhao Y; Malik S; Criqui MH; Allison MA; Budoff MJ; Sandfort V; Wong ND
    BMC Cardiovasc Disord; 2022 Dec; 22(1):536. PubMed ID: 36494811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.